Picture of BBS-Bioactive Bone Substitutes Oyj logo

BONEH — BBS-Bioactive Bone Substitutes Oyj News Story

0.000.00%
fi flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: BBS Expects Decision On Approving CE Marking Application For ARTEBONE Paste In Q2 2024

Sept 13 (Reuters) - BBS-Bioactive Bone Substitutes Oyj  BONEH.HE :
    * PLAN TO COMPLETE MINOR OPEN ISSUES APPROVED - COMPANY UPDATES OUTLOOK ON SCHEDULE OF CE
MARKING
    * NOTIFIED BODY HAS TODAY APPROVED PLAN SUBMITTED BY BBS TO COMPLETE REQUIRED FOUR OPEN
MINOR
MEASURES
    * MEASURES ARE ESTIMATED TO BE COMPLETED IN MARCH-MAY 2024, AFTER WHICH QUALITY SYSTEM MAY
BE
APPROVED
    * FURTHER MEASURES REQUIRED TO ENSURE SUFFICIENT FINANCING TO IMPLEMENT CO'S PLANS FOLLOWING
EXPECTED APPROVAL OF CE MARKING
    * EXPECTS AUTHORITIES’ DECISION ON APPROVING CE MARKING APPLICATION FOR ARTEBONE PASTE
DURING Q2
2024

Source text for Eikon:  ID:nGNEN8SPk 
Further company coverage:  BONEH.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on BBS-Bioactive Bone Substitutes Oyj

See all news